Log in to save to my catalogue

The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants

The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9750863

The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants

About this item

Full title

The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants

Publisher

New York: Nature Publishing Group US

Journal title

Nature biotechnology, 2022-12, Vol.40 (12), p.1845-1854

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with potential resistance to existing drugs emphasizes the need for new therapeutic modalities with broad variant activity. Here we show that ensovibep, a trispecific DARPin (designed ankyrin repeat protein) clinical candidate, can engage the three units of the s...

Alternative Titles

Full title

The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9750863

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9750863

Other Identifiers

ISSN

1087-0156,1546-1696

E-ISSN

1546-1696

DOI

10.1038/s41587-022-01382-3

How to access this item